EP3644988
MITOKETOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING KETONE METABOLISM IN CANCER CELLS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.6.2018EP published:
22.2.2023EP application number:
18822701.1
EPO information:
European Patent Register
Max expiry date:
24.6.2038
Title in English:
MITOKETOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING KETONE METABOLISM IN CANCER CELLSLanguage of the patent:
English
Timeline
Today
25.6.2018EP application
22.2.2023EP Publication
Owner
Name:
Lunella Biotech, Inc.Address:
145 Richmond Road, Ottawa, ON K1Z 1A1, CA
Inventor
Name:
LISANTI, Michael, P.Address:
Ottawa Ontario K1Z 1A1, CA
Name:
SOTGIA, FedericaAddress:
Ottawa Ontario K1Z 1A1, CA
Priority
Number:
201762524829 PDate:
26.6.2017Country:
US
Classification
Categories:
C07D 209/18, C07D 209/04, C07D 209/42, C07D 265/36, C07D 403/14, C07D 417/10, C07D 417/12, C07D 487/04, A61K 31/425, A61K 31/519, A61P 31/00